What's Cool In Road Cycling

Axeon Hagens Berman’s Rice Wins In Redlands

Highland, California – Putting recent adversity aside, Michael Rice won for the Axeon Hagens Berman Cycling Team Friday on the Stage 3 City of Highland Circuit Race at the Redlands Bicycle Classic.

Michael Rice won for the second time this year on Friday at the Redlands Bicycle Classic. (Photo by Davey Wilson.)

It was the team’s 20th victory of the season and came one week to the day that Chad Young succumbed to injuries from a high-speed crash in the final stage of the Tour of the Gila on April 23.

“It has been a real emotional week,” Rice said. “A tough week for everyone. Not just in the team, but I think in cycling in general. So it was really nice to get the win for Chad today. He was a very close friend of mine, actually, so it definitely means a lot.

“The support for Chad has been enormous. It just goes to show how good of a person he was.”

Rice won for the second time this year with help from his four teammates. With only five riders taking the start on Wednesday, Axeon Hagens Berman’s roster was three below the maximum and the smallest of the 25 teams which started the race.

“We were all in for the sprint today,” the 21-year-old Australian said. “I was there and well-positioned by the team. We just kept calm and patient. On the last lap, we used a few guys down the back stretch to put me in the right spot and I had my lead out man, Christopher Blevins, who positioned me well on the climb.”

Race leader Taylor Eisenhart (Holowesko-Citadel Racing presented by Hincapie Sportswear) was runner-up. Two-time Redlands Bicycle Classic winner and 20-year professional Francisco Mancebo (Canyon Bicycles) was third. Blevins held on for eighth, five seconds back, while teammates Jhonatan Narvaez and Geoffrey Curran placed 10th and 19th, respectively, both five seconds back.

Friday’s 93.5 kilometer circuit race saw a breakaway that Axeon Hagens Berman’s Jonny Brown tried desperately to make survive until the 18th of 20 laps around the 4.5-km course. Eisenhart’s Holowesko-Citadel Racing squad kept the gap to the escapees manageable before the UnitedHealthcare Professional Cycling Team ramped up the pace, Axeon Hagens Berman Sport Director Jeff Louder said.

“UnitedHealthcare brought it all back together with one lap to go,” Louder said. “I thought our guys rode intelligently all day. They all stayed calm and rode in support of each other and executed so well.”

“And hats off to Geoffrey,” Louder continued. “He is really starting to mature as a rider and really thinking well on his own. In the morning meeting, he had some real astute, technical advice for the guys and obviously it paid off.”

Rice scored his other victory of the season on the final stage of the San Dimas Stage Race on March 26. He becomes the team’s fourth rider to have won two or more races this year.

Saturday is the City of Redlands Criterium. The 90-minute race has a 4:30 p.m. PDT start time. Sunday’s final stage is the Beaver Medical Group Sunset Road Race (151 km), beginning at 2 p.m.
Michael Rice Podium

Axeon Hagens Berman’s Michael Rice (center) celebrates his stage win with runner-up Taylor Eisenhart (left) and third-place finisher Francisco Mancebo.
(Photo by Davey Wilson.)

About Axeon Hagens Berman
The Axeon Hagens Berman Cycling Team represents the next generation of professional cyclists. Founded in 2009 by former professional cyclist and Olympic bronze medalist Axel Merckx, we are cycling’s premier development program. Through our first eight seasons, we have advanced 21 riders to the WorldTour ranks. Axeon Hagens Berman team and staff work diligently to ensure our program remains the best. Through careful rider selection, instruction and guidance, we annually achieve winning results for a vibrant and original brand that represents the future of the sport. We give future stars their shot to ride against WorldTour teams and prove themselves. #PROVEIT

Like PEZ? Why not subscribe to our weekly newsletter to receive updates and reminders on what's cool in road cycling?

Comments are closed.